GVAX cancer vaccine consisting of a patient's cancer cells modified ex vivo with the gene to produce GM-CSF: Began Phase I dose-scheduling trial of three to fiv

Somatix Therapy Corp. ( SOMA), Alameda, Calif.

Read the full 78 word article

How to gain access

Continue reading with a
two-week free trial.